Specific Diagnostics: Romney Humphries

Romney Humphries has joined the scientific advisory board of Specific Diagnostics. Humphries is the section director of clinical microbiology at Vanderbilt University Medical Center and the former CSO of Accelerate Diagnostics. San Jose, California-based Specific's flagship product is the Specific Reveal Rapid AST platform, which uses a proprietary volatile organic compound metabolomic signature technology to yield drug susceptibility information for bloodstream infections within five hours directly from positive blood cultures. The instrument is CE-IVD-marked and available in Europe. Specific will begin clinical trials in the US for the platform during the summer, it said.